Clinical Trials in the U.S. and China
Gallery: Clinic Facilities Page Slider
With fully integrated operations to advance your drug development program, Frontage supports early Phase I-II clinical studies in the U.S. as well as Phase I-IV clinical studies in China. Listed below are some of our main clinical capabilities:
Our clinical research professionals conduct and manage Phase I-II trials in our Secaucus, NJ-based, 160-bed clinical research center, and Phase I-IV trials in our two China-based, CFDA certified, hospital-based clinical research units - located in Tianjin Teda International Cardiovascular Hospital and First Affiliated Hospital of Jilin University in Changchun.